GSK is to employ doctors to speak about its drugsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2241 (Published 18 March 2014) Cite this as: BMJ 2014;348:g2241
View Full Text
- Zosia Kmietowicz
The UK based pharmaceutical giant GlaxoSmithKline has said that it plans to employ doctors to educate their peers, rather than pay key opinion leaders to speak about its products at conferences and other events.
GSK announced last December that it was changing its marketing practices to end undue influence on prescribers.1 It said that by the start of 2016 it would stop paying doctors fees to speak on its behalf or to …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.